|
[1]ALOTAIBI H, ATABEY N, DIRIL K, et al.Molecular mechanisms of hepatocellular carcinoma[J].Hepatology, 2016, 48 (6) :2047-2063.
|
|
[2]SHERMAN M.Limitations of screening for hepatocellular carcinoma[J].Hepatology, 2015, 1 (2) :161-163.
|
|
[3]LI JY, SONG JY, WANG JF, et al.Value of combined detection of AFP, CA19-9, and CEA in early diagnosis of primary liver cancer[J].J Clin Hepatol, 2017, 33 (7) :1291-1295. (in Chinese) 李嘉妍, 宋金云, 王建芳, 等.AFP、CA19-9、CEA联合检测对原发性肝癌的早期诊断价值[J].临床肝胆病杂志, 2017, 33 (7) :1291-1295.
|
|
[4]XU Y, CHEN GM, FU XQ.Value of miRNA in early diagnosis of tumor and advances in miRNA detection technique[J].Lab Med, 2013, 28 (3) :248-251. (in Chinese) 徐怡, 陈光明, 宓现强.miRNA在肿瘤早期诊断中的价值及其检测技术进展[J].检验医学, 2013, 28 (3) :248-251.
|
|
[5]JI M, LIN HY, ZHAO X, et al.Prognostic significance of miR-NA-26a expression in peripheral blood in patients with primary liver cancer treated with TACE[J/CD].Chin J Liver Dis:Electr Version, 2017, 9 (3) :85-89. (in Chinese) 纪民, 林海燕, 赵旭, 等.外周血miRNA-26a的表达对经TA-CE治疗的原发性肝癌患者预后的意义[J/CD].中国肝脏病杂志:电子版, 2017, 9 (3) :85-89.
|
|
[6]LIN GZ, WANG GY.Research progress on the relationship between microRNA-124 and primary hepatocellular carcinoma[J/CD].Chin J Hepatic Surg:Electronic Edition, 2018, 7 (5) :433-436. (in Chinese) 林国桢, 汪国营.miR-124与原发性肝癌相关性研究进展[J/CD].中华肝脏外科手术电子杂志, 2018, 7 (5) :433-436.
|
|
[7]LI J, LIU Y, DONG D, et al.Evolution of an X-linked primatespecific micro RNA cluster[J].Mol Biol Evol, 2010, 27 (3) :671-683.
|
|
[8]DONG Q, LI C, CHE X, et al.MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells[J].Oncotarget, 2016, 7 (50) :82338-82353.
|
|
[9]JIANG L, YU L, ZHANG X, et al.miR-892b silencing activates NF-κB and promotes aggressiveness in breast cancer[J].Cancer Res, 2016, 76 (5) :1101-1111.
|
|
[10]SHIN SS, PARK SS, HWANG B, et al.MicroRNA-892b influences proliferation, migration and invasion of bladder cancer cells by mediating the p19ARF/cyclin D1/CDK6 and Sp-1/MMP-9 pathways[J].Oncol Rep, 2016, 36 (4) :2313-2320.
|
|
[11]HUANG S, CAI M, ZHENG Y, et al.miR-888 in MCF-7side population sphere cells directly targets E-cadherin[J].J Genet Genomics, 2014, 41 (1) :35-42.
|
|
[12]LEWIS H, LANCE R, TROYER D, et al.miR-888 is an expressed prostatic secretions-derived microRNA that promotes prostate cell growth and migration[J].Cell Cycle, 2014, 13 (2) :227-239.
|
|
[13]National Health and Family Planning Commission of the People’s Republic of China.Diagnosis, management, and treatment of hepatocellular carcinoma (V2017) [J].J Clin Hepatol, 2017, 33 (8) :1419-1431. (in Chinese) 中华人民共和国国家卫生和计划生育委员会.原发性肝癌诊疗规范 (2017年版) [J].临床肝胆病杂志, 2017, 33 (8) :1419-1431.
|
|
[14]Chinese Society of Liver Cancer, Chinese Anti-Cancer Association;Liver Cancer Study Group, Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Pathology, Chinese Anti-Cancer Association, et al.Standardized pathological diagnosis guidelines for primary liver cancer (2015) [J].J Clin Hepatol, 2015, 31 (6) :833-839. (in Chinese) 中国抗癌协会肝癌专业委员会, 中华医学会肝病学分会肝癌学组, 中国抗癌协会病理专业委员会, 等.原发性肝癌规范化病理诊断指南 (2015年版) [J].临床肝胆病杂志, 2015, 31 (6) :833-839.
|
|
[15]LYU GS, CHEN L, WANG HY.Current status and prospects of liver cancer research in China[J].Chin Bull Life Sci, 2015, 27 (3) :237-248. (in Chinese) 吕桂帅, 陈磊, 王红阳.我国肝癌研究的现状与前景[J].生命科学, 2015, 27 (3) :237-248.
|
|
[16]YE SL.Challenges facing the study of primary liver cancer[J].J Clin Hepatol, 2015, 31 (6) :819-823. (in Chinese) 叶胜龙.原发性肝癌研究当前面临的挑战[J].临床肝胆病杂志, 2015, 31 (6) :819-823.
|
|
[17]LIU DY, GUAN LP, SUN JH.Value of combined determination of serum alpha-fetoprotein, carbohydrate antigen 19-9, and carcinoembryonic antigen in the diagnosis of primary liver cancer[J].J China Med Univ, 2003, 32 (6) :574-575. (in Chinese) 刘冬妍, 关丽萍, 孙金华.联合检测血清中AFP, CA19-9, CEA对原发性肝癌诊断的价值[J].中国医科大学学报, 2003, 32 (6) :574-575.
|
|
[18]ZHOU J, YU L, GAO X, et al.Plasma microRNA panel todiagnose hepatitis B virus-related hepatocellular carcinoma[J].J Clin Oncol, 2011, 29 (36) :4781-4788.
|
DownLoad: